MITOLINE®-Enabled 3D Structural Modeling and Boltz AI Capabilities to Be Combined by MitoCareX in a Synergistic Virtual Screening Campaign for selected Transporter Targets Neve Yarak, Israel, June 22, ...
Immunotherapy has revolutionized cancer treatment, with immune checkpoint inhibitors (ICIs) playing a pivotal role. However, current ICIs, primarily monoclonal antibodies, face significant challenges ...
Investigational pill was well-tolerated and doesn't come with food or water restrictions ...
Bayer and Iambic Therapeutics Inc., a clinical-stage life science and technology company developing novel medicines using its AI-driven platform, today announced a drug discovery collaboration in ...
The alternative text for this image may have been generated using AI. Fig. 2: Synthesis and characterization of SiTE. The alternative text for this image may have been generated using AI. Finally, to ...
Leveraging advanced quantum physics models and AI algorithms, XtalPi executed highly efficient virtual screening across ...
Many pharmaceutical targets partition into biomolecular condensates, whose microenvironments can significantly influence drug distribution. Nevertheless, it is unclear how drug design principles ...
Experts from the University of of Dundee's Centre for Targeted Protein Degradation (CeTPD), working with Boehringer Ingelheim scientists, have developed a breakthrough small-molecule drug, a "protein ...
Tilburg, the Netherlands - June 18, 2026 - Alturos Therapeutics B.V., , a biopharmaceutical company focused on developing transformative therapies for neurodegenerative diseases, today announced the ...
A team of researchers from NYU Abu Dhabi and the University of Denver have identified a promising small molecule that could help slow or halt the progression of serious brain diseases such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results